- 专利标题： MUSCARINIC COMBINATION AND ITS USE FOR COMBATING HYPOCHOLINERGIC DISORDERS OF THE CENTRAL NERVOUS SYSTEM
-
申请号： EP16845090.6申请日： 2016-09-09
-
公开(公告)号： EP3347011A1公开(公告)日： 2018-07-18
- 发明人: CHASE, Thomas N. , CLARENCE-SMITH, Kathleen E.
- 申请人： Chase Pharmaceuticals Corporation
- 申请人地址： 1825 K Street N.W. Suite 520 Washington, District of Columbia, 20006 US
- 专利权人： Chase Pharmaceuticals Corporation
- 当前专利权人： Chase Pharmaceuticals Corporation
- 当前专利权人地址： 1825 K Street N.W. Suite 520 Washington, District of Columbia, 20006 US
- 代理机构： Schlich, George
- 优先权： US201562217081P 20150911; US201662351382P 20160617; US201662359426P 20160707
- 国际公布： WO2017044693 20170316
- 主分类号： A61K31/435
- IPC分类号： A61K31/435 ; A61P25/00 ; A61P25/14 ; A61P25/18 ; A61P25/24 ; A61P25/28
摘要：
A combination of a muscarinic cholinergic receptor agonist with a non-anticholinergic antiemetic agent, and the optional addition of an acetyl choline esterase inhibitor, for the treatment of hypocholinergic disorder of the central nervous system.
信息查询
